Benjamin Edwards’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Other funds holding PBE
BP
Benjamin Edwards's PBE Position: Q3 2026 in Review
Benjamin Edwards increased its Invesco Biotechnology & Genome ETF (PBE) stake by 2.3% in Q3 2026, buying an estimated $22K and bringing the position to 10,597 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #800.
Benjamin Edwards first reported a position in PBE in Q1 2026 and has held it in 3 quarters since. 106 funds tracked by Wall St. Rank hold PBE as of Q3 2026.
- Benjamin Edwards held 10,597 shares of Invesco Biotechnology & Genome ETF worth $1.03M as of Q3 2026.
- Benjamin Edwards bought 234 Invesco Biotechnology & Genome ETF shares in Q3 2026, an estimated $22K.
- Invesco Biotechnology & Genome ETF made up 0.01% of Benjamin Edwards's portfolio in Q3 2026, its #800 holding.
- Benjamin Edwards first reported a position in Invesco Biotechnology & Genome ETF in Q1 2026 and has held it in 3 quarters since.
- 106 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.